Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

The resources are part of a nationwide collaboration between Lilly and the American Diabetes Association to destigmatize obesity and encourage stigma-free obesity care. “It’s time to recognize obesity ...

Eli Lilly has revised its revenue forecast for 2024 after seeing weaker-than-expected growth for its diabetes and obesity therapies – but still said sales rose around a third over the prior year.

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

If you have diabetes, nerve damage, circulation problems, and infections can lead to serious foot problems. However, you can take precautions to maintain healthy feet. Managing your diabetes and ...

Maximum plasma concentrations of carvedilol occur 1-2 hours after oral administration. [9] Absolute bioavailability of carvedilol is approximately 23% due to extensive first-pass metabolism. [9 ...

Am J Health Syst Pharm. 2006;63(8):712-714. Drug information specialists are pharmacists whose primary responsibility is the provision of drug information. As with any specialty, formalized ...

Australia’s Odyssey Group has placed an order at Singapore shipbuilder Strategic Marine covering the construction of a 24-meter state-of-the-art multi-purpose survey vessel. Tailored to meet Odyssey ...

November 25, 2024 • Books We Love returns with 350+ new titles handpicked by NPR staff and trusted critics. Find 12 years of recommendations all in one place — that's nearly 4,000 great reads.